Investor overview
360 MSO, LLC is developing the nonclinical business infrastructure supporting Calabasas Allergy Group, a physician-led environmental allergy clinic network planned for Southern California.
The first clinic is anticipated to launch in 2027 and establish the operating foundation for measured expansion.
Calabasas Allergy Group is designed to make clinician-directed environmental allergy evaluation, testing, and ongoing treatment more convenient in communities where reliable repeat access matters.
360 MSO will support the administrative systems, technology, marketing, and operational coordination behind the network, while the physician-owned professional corporation retains responsibility for clinical decisions and patient care. The first clinic is intended to establish a repeatable operating model before measured expansion.
Founder / Managing Member
More than 10 years of experience in software engineering and technology leadership, alongside roughly a decade in sales, marketing, and business development. He leads business planning, technology strategy, operating-system development, and investor coordination for 360 MSO.
Co-Founding Member / Physician Practice Owner
A California-licensed, board-certified family physician with more than 15 years of experience, including emergency medicine. Dr. Firer will own and provide clinical leadership for the associated physician-owned professional corporation.
Request our OneSheet, investor deck, or an introductory conversation.
Any investment will be subject to applicable offering documents and verification of accredited-investor status before a sale is completed.
360 MSO is in development. The anticipated 2027 clinic launch is a planning target and may change. This page provides a general company overview and does not contain the complete terms or risks of any investment.